All Stories

  1. Enhancement of Tenecteplase Thrombolytic Actions Ex Vivo and In Vivo by Deoxyribonuclease I
  2. Stent-Assisted Angioplasty in Symptomatic Intracranial Stenosis without Adjacent Branch Atheromatous Disease: A Randomized Trial with Patients Selected by Using Three-Dimensional Rotational Angiography
  3. Enlarged translesional pressure gradient drives recruitment of leptomeningeal collaterals in medically treated patients with symptomatic middle cerebral artery stenosis
  4. Associations of cerebral perfusion with infarct patterns and early neurological outcomes in symptomatic intracranial atherosclerotic stenosis
  5. Is invasive fractional flow measurement accurate in intracranial stenosis? A computational simulation study
  6. Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke
  7. Thrombolytic agents, more options, more challenges
  8. Associations of Soluble Serum Stimulation‐2 With Functional Outcomes and Death at 1 Year in Acute Ischemic Stroke: A Prospective Cohort Study
  9. Clinical Severity and Outcomes in Large Infarcts With Endovascular Therapy: A Post Hoc Analysis of the ANGEL-ASPECT Trial
  10. Association between serum levels of insulin-like growth factor-binding proteins at admission and outcomes at 3 months after acute ischemic stroke
  11. Stroke Mechanisms in Intracranial Atherosclerotic Disease: A Modified Classification System and Clinical Implications
  12. Endovascular therapy for large ischemic stroke in directly admitted versus transferred patients: A secondary analysis
  13. Collaterals and outcomes after endovascular treatment in acute large vessel occlusion: Disparity by stroke etiologies
  14. COVID-19 vaccination and cerebral small vessel disease progression—A prospective cohort study
  15. Abstract WP270: Prognostic Factors Associated with Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis
  16. Evaluation of Intensive Statins and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Intracranial Artery Plaque Stability: A Prospective Single‐Arm Study
  17. The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy
  18. Chinese Stroke Association guidelines on emergency stroke unit
  19. Ischemic core volume is associated with hemorrhagic transformation post endovascular thrombectomy
  20. More severe cerebral small vessel disease associated with poor leptomeningeal collaterals in symptomatic intracranial atherosclerotic stenosis
  21. Unveiling connections between venous disruption and cerebral small vessel disease using diffusion tensor image analysis along perivascular space (DTI-ALPS): A 7T MRI study
  22. Early vs Delayed Antihypertensive Treatment in Acute Single Subcortical Infarction
  23. Geometry of Terminal Internal Carotid Artery Bifurcation May Be Associated With Middle Cerebral Artery Plaque Ulceration: A Three-Dimensional Rotational Angiography Study
  24. Lipid control and stroke risk in atrial fibrillation patients treated with direct oral anticoagulants and statins
  25. Thromboelastography-Guided Antiplatelet Therapy for Patients with Ischemic Cerebrocardiovascular Diseases: A Systematic Review and Meta-Analysis
  26. Dual antiplatelet therapy for ischemic stroke with intracranial arterial stenosis: a systematic review and meta-analysis
  27. Endovascular therapy in acute ischaemic stroke with large infarction with matched or mismatched clinical-radiological severities: a post-hoc analysis of the ANGEL-ASPECT trial
  28. Clinical implications of haemodynamics in symptomatic intracranial atherosclerotic stenosis by computational fluid dynamics modelling: a systematic review
  29. Comparison of outcomes between stent retriever combined with contact aspiration versus contact aspiration alone in patients without hyperdense artery sign/susceptibility vessel sign
  30. Deviation From Personalized Blood Pressure Targets Correlates With Worse Outcome After Successful Recanalization
  31. Current and Future Treatments of Vascular Cognitive Impairment
  32. Serum heme oxygenase‐1 level predicts clinical outcome after acute ischemic stroke
  33. Prothrombin Complex Concentrate vs Conservative Management in ICH Associated With Direct Oral Anticoagulants
  34. METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients
  35. Editorial: Intracranial atherosclerotic disease: epidemiology, imaging, treatment and prognosis, volume II
  36. Cerebral hemodynamics and stroke risks in symptomatic intracranial atherosclerotic stenosis with internal versus cortical borderzone infarcts: A computational fluid dynamics study
  37. Hemodynamic significance of intracranial atherosclerotic disease and ipsilateral imaging markers of cerebral small vessel disease
  38. Development of a nomogram-based model combining intra- and peritumoral ultrasound radiomics with clinical features for differentiating benign from malignant in Breast Imaging Reporting and Data System category 3–5 nodules
  39. Association of calcium channel blockers with lower incidence of intracranial aneurysm rupture and growth in hypertensive patients
  40. Neuroimaging anomalies in asymptomatic middle cerebral artery steno-occlusive disease with normal-appearing white matter
  41. Deviation from Personalized Blood Pressure Targets Correlates with Worse Outcome after Successful Recanalization
  42. Association of Alternative Anticoagulation Strategies and Outcomes in Patients With Ischemic Stroke While Taking a Direct Oral Anticoagulant
  43. Thrombus migration in patients with acute ischaemic stroke undergoing endovascular thrombectomy
  44. Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications
  45. Cerebral Hemodynamics Underlying Artery-to-Artery Embolism in Symptomatic Intracranial Atherosclerotic Disease
  46. Abstract TP181: Identification Of Hub Genes In Endothelial Cells Under Oscillatory Flow
  47. Abstract WMP84: Symptomatic Intracranial Atherosclerotic Plaques: Different Morphological Features In The Anterior Versus Posterior Circulation
  48. Case report: A rare case of massive peripheral nerve melanotic schwannoma and review of the literature
  49. Good collaterals and better outcomes after EVT for basilar artery occlusion: a systematic review and meta-analysis
  50. Editorial: minor stroke is not minor
  51. Effects of stent shape on focal hemodynamics in intracranial atherosclerotic stenosis: A simulation study with computational fluid dynamics modeling
  52. Clinically Ineffective Reperfusion After Endovascular Therapy in Acute Ischemic Stroke
  53. Associations of Hematological and Biochemical Markers with Intracranial Atherosclerotic Stenosis in Stroke-free Populations: A Systematic Review and Meta-analysis of Observational Studies
  54. Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis
  55. The Mechanism and Role of N6-Methyladenosine (m6A) Modification in Atherosclerosis and Atherosclerotic Diseases
  56. Increased serum uric acid level is associated with better outcome after endovascular treatment for acute ischemic stroke—a prospective cohort study
  57. Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamics
  58. Arterial blood gas analysis aids early differential diagnosis and treatment of primary and secondary hypokalaemic periodic paralysis
  59. Bacterial Signatures of Cerebral Thrombi in Large Vessel Occlusion Stroke
  60. Collateral Flow in Intracranial Atherosclerotic Disease
  61. Causal Relations between Exposome and Stroke: A Mendelian Randomization Study
  62. Hemodynamics Features of Symptomatic Intracranial Atherosclerotic Disease Associated with Severity of Ipsilateral Cerebral Small Vessel Disease (P1-1.Virtual)
  63. Small vessel disease burden may not portend unfavorable outcome after thrombectomy for acute large vessel occlusion
  64. Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management
  65. Validation of external and internal exposome of the findings associated to cerebral small vessel disease: A Mendelian randomization study
  66. Stability of unruptured intracranial aneurysms in the anterior circulation: nomogram models for risk assessment
  67. Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
  68. Genome sequencing reveals the role of rare genomic variants in Chinese patients with symptomatic intracranial atherosclerotic disease
  69. Editorial: Intracranial Atherosclerotic Disease: Epidemiology, Imaging, Treatment and Prognosis
  70. Comparison of Newtonian and Non-newtonian Fluid Models in Blood Flow Simulation in Patients With Intracranial Arterial Stenosis
  71. A prediction of hematoma expansion in hemorrhagic patients using a novel dual-modal machine learning strategy
  72. Elevated Neutrophil to Lymphocyte Ratio Associated With Increased Risk of Recurrent Vascular Events in Older Minor Stroke or TIA Patients
  73. Evolving ischemic stroke subtypes in 15 years: A hospital-based observational study
  74. A Data-Driven Approach to Transfer Function Analysis for Superior Discriminative Power: Optimized Assessment of Dynamic Cerebral Autoregulation
  75. Intracranial arterial stenosis in Caucasian versus Chinese patients with TIA and minor stroke: two contemporaneous cohorts and a systematic review
  76. Intraluminal Thrombus and Outcomes of Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Treatment
  77. Adverse Outcomes Associated With Higher Mean Blood Pressure and Greater Blood Pressure Variability Immediately After Successful Embolectomy in Those With Acute Ischemic Stroke, and the Influence of Pretreatment Collateral Circulation Status
  78. Abstract P572: Cerebral Hemodynamics Underlying Artery-To-Artery Embolism in Symptomatic Intracranial Atherosclerotic Disease
  79. Abstract P678: Elevated Neutrophil to Lymphocyte Ratio Associated With Increased Risk of Recurrent Vascular Events in Older Minor Stroke or TIA Patients
  80. Abstract P549: Total Small Vessel Disease Burden Not Associated With Functional Independence After Endovascular Treatment in Acute Ischemic Stroke Patients
  81. Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China
  82. Response by Lan et al to Letter Regarding Article, “Regional High Wall Shear Stress Associated With Stenosis Regression in Symptomatic Intracranial Atherosclerotic Disease”
  83. Intracranial Atherosclerotic Disease: Epidemiology, Imaging, Treatment and Prognosis
  84. Identifying Biomarkers Associated with Venous Infarction in Acute/Subacute Cerebral Venous Thrombosis
  85. Acute Anticoagulant Therapy for the Treatment of Acute Ischaemic Stroke and Transient Ischaemic Attack
  86. Plaque morphology in acute symptomatic intracranial atherosclerotic disease
  87. Effect of microcirculatory resistance on coronary blood flow and instantaneous wave-free ratio: A computational study
  88. Regional High Wall Shear Stress Associated With Stenosis Regression in Symptomatic Intracranial Atherosclerotic Disease
  89. Cortical Microinfarcts Associated With Worse Outcomes in Patients With Acute Ischemic Stroke Receiving Endovascular Treatment
  90. High-Degree Middle Cerebral Artery Stenosis
  91. Translesional Pressure Gradient Alters Relationship Between Blood Pressure and Recurrent Stroke in Intracranial Stenosis
  92. Hemodynamic Significance of Middle Cerebral Artery Stenosis Associated With the Severity of Ipsilateral White Matter Changes
  93. Small-vessel Vasculopathy Harboured Within Intracranial Large-artery Atherosclerosis (1123)
  94. Screening for chronic conditions with reproductive factors using a machine learning based approach
  95. Characteristics of Wall Shear Stress and Pressure of Intracranial Atherosclerosis Analyzed by a Computational Fluid Dynamics Model: A Pilot Study
  96. State-of-the-art Computational Models of Circle of Willis with Physiological Applications: a Review
  97. Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality
  98. NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
  99. Fasting glucose and HbA1c levels as risk factors for the presence of intracranial atherosclerotic stenosis
  100. Response by Feng et al to Letter Regarding Article, “Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease: Classification and Clinical Implications”
  101. Modifiable risk factors for carotid atherosclerosis: a meta-analysis and systematic review
  102. Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease
  103. Hemodynamics and Stroke Risk in Intracranial Atherosclerotic Disease
  104. Early Identification of High-Risk TIA or Minor Stroke Using Artificial Neural Network
  105. Risk factors for intracranial atherosclerosis: A systematic review and meta-analysis
  106. Sustaining cerebral perfusion in intracranial atherosclerotic stenosis: The roles of antegrade residual flow and leptomeningeal collateral flow
  107. Guidelines for evaluation and management of cerebral collateral circulation in ischaemic stroke 2017
  108. Collateral status as the fifth dimension: warping the time clock for endovascular treatment in acute ischaemic stroke
  109. Estimating current and long-term risks of coronary artery in silico by fractional flow reserve, wall shear stress and low-density lipoprotein filtration rate
  110. Impact of Side Branches on the Computation of Fractional Flow in Intracranial Arterial Stenosis Using the Computational Fluid Dynamics Method
  111. Translesional pressure gradient and leptomeningeal collateral status in symptomatic middle cerebral artery stenosis
  112. Antiplatelet therapy after stroke
  113. Noninvasive fractional flow in intracranial atherosclerotic stenosis: Reproducibility, limitations, and perspectives
  114. Cortical Microinfarcts in Patients with Middle Cerebral Artery Stenosis
  115. Prolonged Perfusion Predicts Recurrent Ischemic Stroke but not Transient Ischemic Attack in Patients with Symptomatic Intracranial Stenosis
  116. Combined Approach of QSAR and Docking Studies for the Design of Local Anaesthetic Agents
  117. Collateral circulation alters downstream hemodynamic stress caused by intracranial atherosclerotic stenosis
  118. Collaterals 2016: Translating the collaterome around the globe
  119. Intracranial atherosclerosis: From anatomy to pathophysiology
  120. Asia Pacific Stroke Conference 2017. Abstracts of the Annual Conference of the Asia Pacific Stroke Organization (APSO) Combined with Stroke Society of Australasia. Nanjing, China, October 26-28, 2017: Abstracts
  121. Cerebral perfusion difference between hemispheres with symptomatic and asymptomatic intracranial arterial stenosis
  122. Good collateral circulation predicts favorable outcomes in intravenous thrombolysis: a systematic review and meta-analysis
  123. The contemporary management of intracranial atherosclerotic disease
  124. Fractional Flow Assessment for the Evaluation of Intracranial Atherosclerosis: A Feasibility Study
  125. Functional assessment of cerebral artery stenosis: A pilot study based on computational fluid dynamics
  126. Diminished Signal Intensities Distal to Intracranial Arterial Stenosis on Time-of-Flight MR Angiography Might Indicate Delayed Cerebral Perfusion
  127. Hemodynamic Impact of Systolic Blood Pressure and Hematocrit Calculated by Computational Fluid Dynamics in Patients with Intracranial Atherosclerosis
  128. Impact of Collateral Status on Successful Revascularization in Endovascular Treatment: A Systematic Review and Meta-Analysis
  129. Computational fluid dynamics of computed tomography angiography to detect the hemodynamic impact of intracranial atherosclerotic stenosis
  130. Dual antiplatelet therapy in stroke and ICAS
  131. Impact of collaterals on the efficacy and safety of endovascular treatment in acute ischaemic stroke: a systematic review and meta-analysis
  132. An Unusual Complication Related to Invasive Electroencephalography Monitoring: Nonhemorrhagic Subdural Fluid Collection
  133. Response to Letter Regarding Article, “Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack: An Updated Systematic Review and Meta-Analysis”
  134. Computational Fluid Dynamics Modeling of Symptomatic Intracranial Atherosclerosis May Predict Risk of Stroke Recurrence
  135. Evaluating Intracranial Atherosclerosis Rather Than Intracranial Stenosis
  136. Magnetic Resonance Angiography Signal Intensity as a Marker of Hemodynamic Impairment in Intracranial Arterial Stenosis
  137. Interobserver Reproducibility of Signal Intensity Ratio on Magnetic Resonance Angiography for Hemodynamic Impact of Intracranial Atherosclerosis
  138. Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
  139. Signal Intensity Ratio as a Novel Measure of Hemodynamic Significance for Intracranial Atherosclerosis
  140. Association Between Metabolic Syndrome and Carotid Atherosclerosis: A Community-Based Study in Hong Kong
  141. Correlation of Large Artery Intracranial Occlusive Disease With Carotid Intima-Media Thickness and Presence of Carotid Plaque